Purchases and Sales Made in Q4 2024 in Tango Therapeutics, Inc. (TNGX)
This table provides information about the institutional ownership of Tango Therapeutics, Inc. (TNGX) during Q4 2024. The information is specifically focused on institutions that hold shares of Tango Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
SELL
|
- |
-26.4K- 5.98% |
$73.5K - $197K
|
414K
$618K
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-26.5K- 20.99% |
$74K - $198K
|
99.8K
$149K
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-56.6K- 10.42% |
$158K - $422K
|
487K
$725K
|
|
|
Feb 14, 2025
Q4 2024
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-124K- 20.72% |
$346K - $926K
|
475K
$708K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.07M- 39.62% |
$2.98M - $7.96M
|
1.63M
$2.42M
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.09M- 46.89% |
$3.03M - $8.11M
|
1.23M
$1.83M
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.68M- 33.4% |
$4.68M - $12.5M
|
3.35M
$4.98M
|
|
|
Feb 14, 2025
Q4 2024
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-2.7M- 20.25% |
$7.53M - $20.1M
|
10.6M
$15.8M
|